Cargando...
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
OBJECTIVE: To examine outcomes among patients who were treated with the targeted anti-cytokine agents, anakinra or tocilizumab, for COVID-19 -related cytokine storm (COVID19-CS). METHODS: We conducted a retrospective cohort study of all SARS-coV2-RNA-positive patients treated with tocilizumab or ana...
Gardado en:
| Publicado en: | Int J Infect Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Southern California Permanente Medical Group. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7406519/ https://ncbi.nlm.nih.gov/pubmed/32768693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.07.081 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|